Keros Therapeutics (KROS) Other Non Operating Income (2019 - 2025)
Historic Other Non Operating Income for Keros Therapeutics (KROS) over the last 7 years, with Q3 2025 value amounting to -$253000.0.
- Keros Therapeutics' Other Non Operating Income fell 17500.0% to -$253000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year decrease of 5560.54%. This contributed to the annual value of -$954000.0 for FY2024, which is 36310.68% down from last year.
- As of Q3 2025, Keros Therapeutics' Other Non Operating Income stood at -$253000.0, which was down 17500.0% from -$221000.0 recorded in Q2 2025.
- In the past 5 years, Keros Therapeutics' Other Non Operating Income registered a high of $762000.0 during Q3 2022, and its lowest value of -$1.4 million during Q4 2022.
- Its 5-year average for Other Non Operating Income is -$156210.5, with a median of -$101000.0 in 2021.
- Within the past 5 years, the most significant YoY rise in Keros Therapeutics' Other Non Operating Income was 65620.44% (2022), while the steepest drop was 128811.88% (2022).
- Over the past 5 years, Keros Therapeutics' Other Non Operating Income (Quarter) stood at -$101000.0 in 2021, then crashed by 1288.12% to -$1.4 million in 2022, then surged by 103.99% to $56000.0 in 2023, then crashed by 508.93% to -$229000.0 in 2024, then dropped by 10.48% to -$253000.0 in 2025.
- Its Other Non Operating Income stands at -$253000.0 for Q3 2025, versus -$221000.0 for Q2 2025 and -$338000.0 for Q1 2025.